Suppr超能文献

委内瑞拉亚马逊地区瓜希沃和皮拉奥土著社区中疟疾候选疫苗抗原 MSP3 和 GLURP 的天然免疫应答。

Naturally acquired immune responses to malaria vaccine candidate antigens MSP3 and GLURP in Guahibo and Piaroa indigenous communities of the Venezuelan Amazon.

机构信息

Institut für Tropenmedizin, Eberhard Karls Universität Tübingen, Tübingen, Germany.

出版信息

Malar J. 2012 Feb 15;11:46. doi: 10.1186/1475-2875-11-46.

Abstract

BACKGROUND

Malaria transmission in most of Latin America can be considered as controlled. In such a scenario, parameters of baseline immunity to malaria antigens are of specific interest with respect to future malaria eradication efforts.

METHODS

A cross-sectional study was carried out in two indigenous population groups in Amazonas/Venezuela. Data from the regional malaria documentation system were extracted and participants from the ethnic groups of the Guahibo (n = 180) and Piaroa (n = 295) were investigated for the presence of Plasmodium parasites and naturally acquired antibodies to Plasmodium falciparum antigens in serum. The GMZ2 vaccine candidate proteins MSP3 and GLURP were chosen as serological markers.

RESULTS

The incidence of P. falciparum in both communities was found to be less than 2%, and none of the participants harboured P. falciparum at the time of the cross-sectional. Nearly a quarter of the participants (111/475; 23,4%) had positive antibody titres to at least one of the antigens. 53/475 participants (11.2%) were positive for MSP3, and 93/475 participants (19.6%) were positive for GLURP. High positive responses were detected in 36/475 participants (7.6%) and 61/475 participants (12.8%) for MSP3 and GLURP, respectively. Guahibo participants had significantly higher antibody titres than Piaroa participants.

CONCLUSIONS

Considering the low incidence of P. falciparum, submicroscopical infections may explain the comparatively high anti-P. falciparum antibody concentrations.

摘要

背景

拉丁美洲大部分地区的疟疾传播已被认为得到控制。在这种情况下,疟疾抗原基础免疫力的参数对于未来的疟疾消除工作具有特殊意义。

方法

在委内瑞拉亚马逊州的两个土著人群中进行了一项横断面研究。从区域疟疾档案系统中提取数据,并对瓜伊博族(n=180)和皮拉奥族(n=295)的参与者进行了调查,以确定他们是否存在疟原虫寄生虫以及血清中针对恶性疟原虫抗原的天然获得性抗体。选择 GMZ2 疫苗候选蛋白 MSP3 和 GLURP 作为血清学标志物。

结果

发现这两个社区的恶性疟原虫发病率均低于 2%,且在横断面调查时,没有参与者携带恶性疟原虫。近四分之一的参与者(111/475;23.4%)对至少一种抗原具有阳性抗体滴度。475 名参与者中有 53 名(11.2%)对 MSP3 呈阳性,475 名参与者中有 93 名(19.6%)对 GLURP 呈阳性。在 36/475 名参与者(7.6%)和 61/475 名参与者(12.8%)中分别检测到 MSP3 和 GLURP 的高阳性反应。瓜伊博族参与者的抗体滴度明显高于皮拉奥族参与者。

结论

考虑到恶性疟原虫的低发病率,亚微观感染可能解释了相对较高的抗恶性疟原虫抗体浓度。

相似文献

9
Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?
Trop Med Int Health. 2008 Feb;13(2):229-37. doi: 10.1111/j.1365-3156.2007.01994.x.

引用本文的文献

1
Malaria & mRNA Vaccines: A Possible Salvation from One of the Most Relevant Infectious Diseases of the Global South.
Acta Parasitol. 2023 Dec;68(4):916-928. doi: 10.1007/s11686-023-00712-y. Epub 2023 Oct 12.
2
[Malarial antigens in the era of mRNA vaccines].
Monatsschr Kinderheilkd. 2022;170(9):828-838. doi: 10.1007/s00112-022-01554-0. Epub 2022 Jul 14.
5
High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection.
Mol Cell Proteomics. 2019 Apr;18(4):642-656. doi: 10.1074/mcp.RA118.000992. Epub 2019 Jan 10.
8
Parasite Specific Antibody Increase Induced by an Episode of Acute P. falciparum Uncomplicated Malaria.
PLoS One. 2015 Apr 23;10(4):e0124297. doi: 10.1371/journal.pone.0124297. eCollection 2015.
9
The origin and diversification of the merozoite surface protein 3 (msp3) multi-gene family in Plasmodium vivax and related parasites.
Mol Phylogenet Evol. 2014 Sep;78:172-84. doi: 10.1016/j.ympev.2014.05.013. Epub 2014 May 23.
10
Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24.
Clin Vaccine Immunol. 2014 Jun;21(6):886-97. doi: 10.1128/CVI.00179-14. Epub 2014 Apr 30.

本文引用的文献

2
Assessment of routine malaria diagnosis in the Venezuelan Amazon.
Trans R Soc Trop Med Hyg. 2011 May;105(5):262-8. doi: 10.1016/j.trstmh.2011.01.002. Epub 2011 Mar 3.
3
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon.
Vaccine. 2010 Sep 24;28(41):6698-703. doi: 10.1016/j.vaccine.2010.07.085. Epub 2010 Aug 7.
5
New medicines for malaria.
Wien Klin Wochenschr. 2010 Mar;122 Suppl 1:19-22. doi: 10.1007/s00508-010-1330-4.
6
Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008.
Emerg Infect Dis. 2010 Mar;16(3):392-9. doi: 10.3201/eid1603.090732.
9
Immune response to Plasmodium vivax has a potential to reduce malaria severity.
Clin Exp Immunol. 2010 May;160(2):233-9. doi: 10.1111/j.1365-2249.2009.04075.x. Epub 2009 Dec 17.
10
A rapid malaria appraisal in the Venezuelan Amazon.
Malar J. 2009 Dec 11;8:291. doi: 10.1186/1475-2875-8-291.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验